See more : UmweltBank AG (UBK.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Analytica Limited (ALT.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Analytica Limited, a leading company in the Medical – Devices industry within the Healthcare sector.
- Minds + Machines Group Limited (MMX.L) Income Statement Analysis – Financial Results
- Regional Brands Inc. (RGBD) Income Statement Analysis – Financial Results
- Celanese Corporation (0HUR.L) Income Statement Analysis – Financial Results
- Samick THK Co., Ltd. (004380.KS) Income Statement Analysis – Financial Results
- Nephros, Inc. (NEPH) Income Statement Analysis – Financial Results
Analytica Limited (ALT.AX)
About Analytica Limited
Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East. The company's lead product includes PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 19.36K | 7.24K | 11.37K | 54.81K | 47.42K | 73.41K | 190.80K | 73.82K | 0.00 | 498.08K | 4.88K | 6.10K | 1.80K | 247.62K | 164.89K | 249.81K | 194.25K | 619.67K |
Cost of Revenue | 8.62K | 3.50K | 16.80K | 17.19K | 21.99K | 37.66K | 81.39K | 22.78K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 406.17K |
Gross Profit | 10.74K | 3.75K | -5.43K | 37.62K | 25.43K | 35.75K | 109.41K | 51.04K | 0.00 | 498.08K | 4.88K | 6.10K | 1.80K | 247.62K | 164.89K | 249.81K | 194.25K | 213.50K |
Gross Profit Ratio | 55.47% | 51.75% | -47.75% | 68.64% | 53.62% | 48.70% | 57.34% | 69.14% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 34.45% |
Research & Development | 525.60K | 504.18K | 823.44K | 1.66M | 1.14M | 2.34M | 2.47M | 2.84M | 2.20M | 1.15M | 909.93K | 374.58K | 601.23K | 508.45K | 385.95K | 128.41K | 388.21K | 518.12K |
General & Administrative | 1.63M | 1.52M | 1.41M | 2.46M | 1.63M | 922.42K | 1.44M | 534.03K | 210.08K | 132.54K | 494.64K | 424.48K | 455.83K | 1.20M | 541.86K | 480.21K | 790.66K | 1.11M |
Selling & Marketing | 297.79K | 183.02K | 128.88K | 323.80K | 374.28K | 315.05K | 1.69M | 2.29M | 396.62K | 145.37K | 16.24K | 26.05K | 169.97K | 303.56K | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.93M | 1.71M | 1.53M | 2.78M | 2.00M | 1.24M | 3.13M | 2.83M | 606.70K | 277.91K | 510.88K | 450.53K | 625.80K | 1.51M | 541.86K | 480.21K | 790.66K | 1.11M |
Other Expenses | 49.15K | 32.35K | 36.41K | -1.62M | 14.01K | 860.73K | 248.20K | 668.09K | 995.32K | 221.14K | 381.67K | 26.93K | 85.21K | 105.98K | 54.03K | 80.81K | 2.19M | 2.16M |
Operating Expenses | 2.50M | 2.24M | 2.39M | 2.82M | 3.16M | 4.44M | 5.85M | 6.33M | 3.80M | 1.65M | 1.80M | 852.04K | 1.31M | 2.12M | 981.85K | 689.42K | 3.37M | 3.78M |
Cost & Expenses | 2.51M | 2.25M | 2.41M | 2.84M | 3.18M | 4.48M | 5.93M | 6.35M | 3.80M | 1.65M | 1.80M | 852.04K | 1.31M | 2.12M | 981.85K | 689.42K | 3.37M | 4.19M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 12.38K | 0.00 | 0.00 | 0.00 | 22.31K | 0.00 | 32.01K | 5.33K | 35.61K | 56.22K | 50.85K | 20.45K | 27.60K | 40.54K |
Interest Expense | 6.49K | 58.50K | 227.00 | 2.78K | 277.00 | 231.00 | 2.27K | 384.00 | 3.10K | 229.00 | 18.76K | 5.33K | 20.64K | 29.75K | 12.51K | 6.58K | 0.00 | 0.00 |
Depreciation & Amortization | 23.52K | 9.20K | 8.63K | 10.85K | 12.57K | 14.42K | 117.79K | 93.37K | 16.91K | 15.40K | 97.93K | 12.84K | 13.25K | 9.64K | 10.93K | 8.61K | 2.06M | 2.03M |
EBITDA | -2.21M | -1.44M | -1.61M | -2.04M | -2.15M | -3.24M | -3.76M | -5.22M | -3.16M | -1.12M | -2.11M | -185.00K | -1.25M | -1.86M | -806.03K | -574.55K | -1.01M | -5.20M |
EBITDA Ratio | -11,400.68% | -19,874.48% | -14,175.20% | -3,723.30% | -4,526.41% | -4,413.64% | -1,971.37% | -7,073.38% | 0.00% | -224.89% | -43,141.86% | -3,032.77% | -69,663.78% | -752.12% | -488.81% | -230.00% | -522.46% | -839.67% |
Operating Income | -2.23M | -1.45M | -1.62M | -2.05M | -3.13M | -4.40M | -5.74M | -6.28M | -3.80M | -1.15M | -1.80M | -845.94K | -1.31M | -2.12M | -981.85K | -439.61K | -3.18M | -3.57M |
Operating Income Ratio | -11,522.15% | -20,001.50% | -14,251.16% | -3,743.09% | -6,610.96% | -5,998.55% | -3,008.56% | -8,505.87% | 0.00% | -230.78% | -36,835.94% | -13,867.89% | -72,802.00% | -856.02% | -595.44% | -175.98% | -1,635.00% | -576.30% |
Total Other Income/Expenses | -7.75K | 720.88K | 892.11K | 431.24K | 975.56K | 1.15M | 1.86M | 963.77K | 621.81K | 13.70K | -424.42K | 642.77K | 22.60K | 217.87K | 152.39K | -150.13K | 99.55K | -43.27K |
Income Before Tax | -2.24M | -1.51M | -1.62M | -2.05M | -2.16M | -3.25M | -3.88M | -5.32M | -3.18M | -1.14M | -2.22M | -203.18K | -1.29M | -1.90M | -829.46K | -589.74K | -3.08M | -3.61M |
Income Before Tax Ratio | -11,562.18% | -20,809.03% | -14,253.15% | -3,748.15% | -4,553.51% | -4,433.60% | -2,034.29% | -7,200.37% | 0.00% | -228.03% | -45,532.97% | -3,330.75% | -71,546.50% | -768.03% | -503.02% | -236.08% | -1,583.75% | -583.28% |
Income Tax Expense | 6.49K | 850.00K | 779.81K | 2.78K | 975.84K | 1.15M | 1.86M | 964.16K | 624.91K | 13.93K | -405.66K | 648.10K | 43.24K | 247.62K | 164.89K | -143.54K | 99.55K | -3.61M |
Net Income | -2.25M | -2.36M | -2.40M | -2.06M | -2.16M | -3.25M | -3.88M | -5.32M | -3.18M | -1.14M | -2.22M | -203.18K | -1.29M | -1.90M | -829.46K | -589.74K | -3.08M | -3.61M |
Net Income Ratio | -11,595.70% | -32,542.81% | -21,113.44% | -3,753.22% | -4,553.51% | -4,433.60% | -2,034.29% | -7,200.37% | 0.00% | -228.03% | -45,532.97% | -3,330.75% | -71,546.50% | -768.03% | -503.02% | -236.08% | -1,583.75% | -583.28% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 | -0.02 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 | -0.02 |
Weighted Avg Shares Out | 4.61B | 3.57B | 3.52B | 3.35B | 2.84B | 2.31B | 1.42B | 962.10M | 708.54M | 599.99M | 573.58M | 445.78M | 445.78M | 343.70M | 299.80M | 206.00M | 301.69M | 184.94M |
Weighted Avg Shares Out (Dil) | 4.61B | 3.57B | 3.52B | 3.35B | 2.84B | 2.31B | 1.42B | 962.10M | 708.54M | 599.99M | 573.58M | 445.78M | 445.78M | 343.70M | 299.80M | 206.00M | 301.69M | 217.23M |
Source: https://incomestatements.info
Category: Stock Reports